ANDA 62268, held by Chartwell Rx. Cloxacillin Sodium.
As of Nov 16, 2026, ANDA 62268 (Cloxacillin Sodium), held by Chartwell Rx, was first approved by FDA on Sep 15, 1980, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 15, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cloxacillin SodiumEQ 125MG BASE/5ML ยท for solution;oral | Cloxacillin Sodium | Discontinued |
| Jul 7, 2000 | Supplement 20Manufacturing | Approved | None posted |
| Dec 22, 1997 | Supplement 19Manufacturing | Approved | None posted |
| Aug 19, 1997 | Supplement 18Manufacturing | Approved | None posted |
| Aug 30, 1996 | Supplement 17Manufacturing | Approved | None posted |
| Dec 22, 1994 | Supplement 16Manufacturing | Approved | None posted |
| Jan 13, 1994 | Supplement 14Labeling | Approved | None posted |
| Jun 29, 1993 | Supplement 15Labeling | Approved | None posted |
| Sep 15, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters